Senate rejects Makary FDA nomination by 2026-12-31

Makary's nomination will face overwhelming bipartisan opposition due to his contentious policy views and lack of consensus support. Senate procedural votes and public hearings will fail to secure the required majority.

Implied probability (Yes)

80%